Jailendra Singh
Stock Analyst at Truist Securities
(1.19)
# 3,087
Out of 4,583 analysts
156
Total ratings
36.62%
Success rate
-21.94%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Reiterates: Buy | $383 | $304.55 | +25.76% | 4 | Sep 11, 2024 | |
| PHR Phreesia | Maintains: Buy | $29 → $31 | $24.05 | +28.90% | 4 | Sep 6, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $197 → $207 | $215.90 | -4.12% | 5 | Sep 3, 2024 | |
| EVH Evolent Health | Maintains: Buy | $33 | $30.97 | +6.55% | 2 | Aug 27, 2024 | |
| DOCS Doximity | Reiterates: Hold | $31 → $35 | $40.71 | -14.03% | 5 | Aug 14, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $50 → $59 | $57.53 | +2.56% | 3 | Aug 9, 2024 | |
| RCM R1 RCM | Maintains: Hold | $16 → $14 | $14.16 | +1.02% | 7 | Aug 8, 2024 | |
| PGNY Progyny | Maintains: Buy | $37 → $33 | $16.88 | +95.48% | 7 | Aug 7, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $15 → $10 | $9.56 | +4.66% | 15 | Aug 2, 2024 | |
| MEDP Medpace Holdings | Initiates: Hold | $415 | $373.53 | +11.10% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $292 → $300 | $245.92 | +21.99% | 10 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $23 | $16.91 | +36.05% | 7 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $11.05 | +26.75% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $9 | $4.27 | +111.02% | 12 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $4.14 | +57.19% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $24 | $19.47 | +23.30% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7.5 → $8 | $7.29 | +9.74% | 11 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $225 | $2.25 | +9,900.00% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $100 | $9.88 | +912.15% | 5 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.09 | +217.85% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $16.36 | +162.84% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $4.79 | +401.04% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.97 | +103.05% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $110.88 | -47.69% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $9.73 | +362.58% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $506.87 | -34.30% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.09 | +191.26% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $20.57 | - | 3 | Jan 15, 2021 |
ICON Public Limited Company
Sep 11, 2024
Reiterates: Buy
Price Target: $383
Current: $304.55
Upside: +25.76%
Phreesia
Sep 6, 2024
Maintains: Buy
Price Target: $29 → $31
Current: $24.05
Upside: +28.90%
Veeva Systems
Sep 3, 2024
Maintains: Hold
Price Target: $197 → $207
Current: $215.90
Upside: -4.12%
Evolent Health
Aug 27, 2024
Maintains: Buy
Price Target: $33
Current: $30.97
Upside: +6.55%
Doximity
Aug 14, 2024
Reiterates: Hold
Price Target: $31 → $35
Current: $40.71
Upside: -14.03%
Astrana Health
Aug 9, 2024
Maintains: Buy
Price Target: $50 → $59
Current: $57.53
Upside: +2.56%
R1 RCM
Aug 8, 2024
Maintains: Hold
Price Target: $16 → $14
Current: $14.16
Upside: +1.02%
Progyny
Aug 7, 2024
Maintains: Buy
Price Target: $37 → $33
Current: $16.88
Upside: +95.48%
Teladoc Health
Aug 2, 2024
Maintains: Hold
Price Target: $15 → $10
Current: $9.56
Upside: +4.66%
Medpace Holdings
Aug 1, 2024
Initiates: Hold
Price Target: $415
Current: $373.53
Upside: +11.10%
Jul 23, 2024
Maintains: Buy
Price Target: $292 → $300
Current: $245.92
Upside: +21.99%
Jul 18, 2024
Maintains: Hold
Price Target: $13 → $23
Current: $16.91
Upside: +36.05%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $11.05
Upside: +26.75%
Jun 28, 2024
Maintains: Buy
Price Target: $14 → $9
Current: $4.27
Upside: +111.02%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $4.14
Upside: +57.19%
May 15, 2024
Maintains: Buy
Price Target: $28 → $24
Current: $19.47
Upside: +23.30%
Mar 1, 2024
Maintains: Hold
Price Target: $7.5 → $8
Current: $7.29
Upside: +9.74%
Sep 7, 2022
Initiates: Hold
Price Target: $225
Current: $2.25
Upside: +9,900.00%
Sep 7, 2022
Initiates: Hold
Price Target: $100
Current: $9.88
Upside: +912.15%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.09
Upside: +217.85%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $16.36
Upside: +162.84%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $4.79
Upside: +401.04%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.97
Upside: +103.05%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $110.88
Upside: -47.69%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $9.73
Upside: +362.58%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $506.87
Upside: -34.30%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.09
Upside: +191.26%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $20.57
Upside: -